Chapter 5

*Muscular Dystrophies*

2010;**73**(12):623-627

1983;**80**(11):3531-3535

1987;**81**(2-3):301-320

2003;**348**(2):73-76

[20] Guidotti A et al. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proceedings of the National Academy of Sciences of the United States of America.

[21] Ono S et al. Neuropathological changes of the brain in myotonic dystrophy-some new observations. Journal of the Neurological Sciences.

[22] Kassubek J et al. Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: A controlled 3-dimensional magnetic resonance imaging study. Neuroscience Letters.

[23] Meola G et al. Executive dysfunction

and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscular Disorders. 2003;**13**(10):813-821

[24] Liepert J et al. Central fatigue assessed by transcranial magnetic stimulation. Muscle & Nerve. 1996;**19**(11):1429-1434

[25] Di Lazzaro V et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clinical Neurophysiology. 2000;**111**(5):794-799

[26] Di Lazzaro V et al. Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: Direct recording of epidural activity in conscious humans. Journal of

Neurophysiology. 2006;**96**(4):1765-1771

[19] Lin KP et al. Fatigue in colchicine myopathy: A study of transcranial magnetic stimulation. Journal of the Chinese Medical Association.

[27] Galaz-Vega R et al. Glutamate regulates dystrophin-71 levels in glia cells. Neurochemical Research.

[28] Yoshihara Y et al. Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophindeficient mdx mice. Neuroscience.

[30] Castel-Lacanal E et al. Induction of cortical plastic changes in wrist muscles by paired associative stimulation in the recovery phase of stroke patients. Neurorehabilitation and Neural Repair.

2005;**30**(2):237-243

2003;**117**(2):391-395

[29] Rossi S et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology.

2009;**120**(12):2008-2039

2009;**23**(4):366-372

[31] Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clinical Neurophysiology.

[32] Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annual Review of Biomedical Engineering. 2007;**9**:527-565

[33] Hoogendam JM, Ramakers GM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimulation.

2006;**117**(12):2584-2596

2010;**3**(2):95-118

**60**
